CRISPR QC Sees Quality Control Need for Gene Sequencing - San Diego Business Journal

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene therapy manufacturing Expansion underscores the commitment of QIAGEN to help accelerate the development of safe and effective b... L'articolo QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control è un contenuto originale di 01net.

CRISPR QC Sees Quality Control Need for Gene Sequencing - San Diego Business Journal

SAN DIEGO – While research and development of gene editing-based therapies has exploded across the biotech industry in recent years, many companies still lack a process to prevent bad chemical inputs that could alter their results, from Ross Bundy’s point of view. Bundy is the co-founder, president and CEO of CRISPR QC, which provides an […]